HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evelyne Decullier Selected Research

Epistaxis (Nosebleed)

4/2020Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial.
1/2019Efficacy of TIMOLOL nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia. A double-blind, randomized, placebo-controlled trial.
1/2016Effect of Bevacizumab Nasal Spray on Epistaxis Duration in Hereditary Hemorrhagic Telangectasia: A Randomized Clinical Trial.
1/2015Dose - response relationship of bevacizumab in hereditary hemorrhagic telangiectasia.
5/2014ELLIPSE Study: a Phase 1 study evaluating the tolerance of bevacizumab nasal spray in the treatment of epistaxis in hereditary hemorrhagic telangiectasia.
3/2012Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.
2/2012Ex vivo study of bevacizumab transport through porcine nasal mucosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Evelyne Decullier Research Topics

Disease

10Neoplasms (Cancer)
01/2022 - 04/2006
8Hereditary Hemorrhagic Telangiectasia
04/2020 - 03/2010
7Peritoneal Neoplasms
01/2022 - 09/2013
7Epistaxis (Nosebleed)
04/2020 - 02/2012
6Skin Neoplasms (Skin Cancer)
07/2018 - 08/2010
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2018 - 06/2009
4Macular Degeneration (Age-Related Maculopathy)
01/2022 - 11/2013
3Choroidal Neovascularization
07/2022 - 01/2022
3Uveitis
01/2020 - 06/2017
3Vascular Malformations
04/2013 - 03/2010
2Carcinoma (Carcinomatosis)
01/2022 - 08/2014
2Neoplasm Metastasis (Metastasis)
01/2022 - 10/2019
2Melanoma (Melanoma, Malignant)
11/2021 - 11/2017
2Prostatic Neoplasms (Prostate Cancer)
08/2021 - 03/2015
2Syphilis
01/2020 - 06/2017
2Basal Cell Carcinoma (Rodent Ulcer)
07/2018 - 01/2018
2Virus Diseases (Viral Diseases)
04/2018 - 05/2004
2Trigeminal Neuralgia (Tic Douloureux)
10/2008 - 12/2007
1Telangiectasis (Telangiectasia)
01/2020
1Anastomotic Leak
01/2020
1Ischemic Stroke
12/2019
1Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2019
1Intracranial Aneurysm (Cerebral Aneurysm)
12/2019
1Hemorrhage
12/2019
1Stomach Neoplasms (Stomach Cancer)
10/2019
1Bowen's Disease (Disease, Bowen)
07/2018
1Sarcoidosis (Schaumann Disease)
04/2018
1Tuberculosis (Tuberculoses)
04/2018
1Ovarian Epithelial Carcinoma
01/2018
1Radiation-Induced Neoplasms (Neoplasms, Radiation Induced)
03/2016
1Rectal Neoplasms (Rectal Cancer)
03/2016
1Colorectal Neoplasms (Colorectal Cancer)
12/2015
1Ovarian Neoplasms (Ovarian Cancer)
09/2015
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
12/2014
1Hepatocellular Carcinoma (Hepatoma)
06/2014
1Stroke (Strokes)
01/2014
1Edema (Dropsy)
04/2013
1Dyspnea (Shortness of Breath)
04/2013
1Atrial Fibrillation
04/2013
1Mitral Valve Insufficiency (Mitral Regurgitation)
04/2013
1Heart Failure
03/2012
1High Cardiac Output
03/2012
1Inborn Genetic Diseases (Disease, Hereditary)
02/2012
1Mucopolysaccharidoses
11/2011
1Pain (Aches)
11/2010
1Chronic Renal Insufficiency
04/2010
1Chronic Kidney Failure (Chronic Renal Failure)
04/2010

Drug/Important Bio-Agent (IBA)

9Bevacizumab (Avastin)FDA Link
01/2018 - 02/2012
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2015
3Nasal SpraysIBA
01/2019 - 05/2014
3Sirolimus (Rapamycin)FDA Link
01/2018 - 06/2009
3Calcineurin InhibitorsIBA
01/2018 - 06/2009
3Ranibizumab (Lucentis)FDA Link
01/2018 - 11/2013
2afliberceptIBA
07/2022 - 01/2022
2Tacrolimus (Prograf)FDA LinkGeneric
04/2020 - 08/2014
2AerosolsIBA
01/2020 - 01/2020
2Tuberculin (PPD)IBA
01/2020 - 06/2017
2C-Reactive ProteinIBA
01/2020 - 06/2017
2EverolimusFDA Link
12/2014 - 08/2010
1Fluorescein (Funduscein)FDA LinkGeneric
01/2022
1IA 4IBA
11/2021
1Hyaluronic Acid (Hyaluronan)IBA
08/2021
1Immunosuppressive Agents (Immunosuppressants)IBA
04/2020
1Ointments (Pastes)IBA
04/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Pharmaceutical PreparationsIBA
01/2019
1Timolol (Blocadren)FDA LinkGeneric
01/2019
1HLA-B27 Antigen (HLA B27 Antigen)IBA
04/2018
1Azathioprine (Imuran)FDA LinkGeneric
04/2017
1AntibodiesIBA
04/2017
1Monoclonal AntibodiesIBA
01/2016
1Ethiodized Oil (Ethiodol)FDA Link
06/2014
1HSP27 Heat-Shock ProteinsIBA
09/2013
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2013
1Brain Natriuretic Peptide (Natrecor)FDA Link
04/2013
1miglustat (Zavesca)FDA Link
11/2011
1Analgesics (Analgesic Drugs)IBA
11/2010
1CalcineurinIBA
08/2010
1HematinicsIBA
04/2010
1Hormones (Hormone)IBA
04/2008

Therapy/Procedure

8Cytoreduction Surgical Procedures
01/2022 - 09/2013
8Hyperthermic Intraperitoneal Chemotherapy
01/2022 - 09/2013
7Liver Transplantation
07/2018 - 03/2010
4Drug Therapy (Chemotherapy)
01/2020 - 08/2014
3Intravitreal Injections
01/2022 - 11/2013
3Transplantation
11/2021 - 04/2006
3Radiotherapy
08/2021 - 03/2015
3Therapeutics
12/2019 - 05/2004
2Organ Transplantation
11/2021 - 11/2017
2Secondary Prevention
01/2018 - 01/2014
2Kidney Transplantation
04/2017 - 07/2012
2Microvascular Decompression Surgery
10/2008 - 12/2007
1Injections
01/2022
1Aftercare (After-Treatment)
04/2020
1Retreatment
12/2019
1Nasal Surgical Procedures
01/2019
1Splenectomy
01/2016
1Neoadjuvant Therapy
08/2014
1Neurological Rehabilitation
01/2014
1Continuous Positive Airway Pressure
11/2010